Literature DB >> 29611552

On the article "Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window".

Pancras C Wong1, Jing Yang1.   

Abstract

Entities:  

Year:  2018        PMID: 29611552      PMCID: PMC5879527          DOI: 10.21037/atm.2017.11.31

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  2 in total

1.  Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window.

Authors:  Shauna L French; Justin R Hamilton
Journal:  Ann Transl Med       Date:  2017-12

2.  Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.

Authors:  Pancras C Wong; Dietmar Seiffert; J Eileen Bird; Carol A Watson; Jeffrey S Bostwick; Mary Giancarli; Nick Allegretto; Ji Hua; David Harden; Jocelyne Guay; Mario Callejo; Michael M Miller; R Michael Lawrence; Jacques Banville; Julia Guy; Brad D Maxwell; E Scott Priestley; Anne Marinier; Ruth R Wexler; Michel Bouvier; David A Gordon; William A Schumacher; Jing Yang
Journal:  Sci Transl Med       Date:  2017-01-04       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.